Revvity Q2 2020 Earnings Report
Key Takeaways
PerkinElmer reported a strong second quarter with a 12% increase in revenue to $811.7 million and a GAAP EPS of $1.23. Adjusted EPS was $1.57. The Diagnostics segment saw substantial growth, offsetting a decline in the Discovery & Analytical Solutions segment.
Revenue reached $811.7 million, representing a 12% reported growth and 13% organic growth.
GAAP EPS from continuing operations was reported at $1.23.
Adjusted EPS reached $1.57, compared to $1.00 in the second quarter of 2019.
Operating income from continuing operations was $175.6 million, with an operating profit margin of 21.6%.
Revvity
Revvity
Revvity Revenue by Segment
Forward Guidance
The Company forecasts GAAP revenue in the range of $760 million to $860 million, GAAP earnings per share from continuing operations of $0.85 to $1.20 and, on a non-GAAP basis, adjusted earnings per share of $1.18 to $1.53 for the third quarter of 2020.
Revenue & Expenses
Visualization of income flow from segment revenue to net income